Loading

Loading.

Loading..

Loading...

SPER Market Research


Global Veterinary Diagnostics Market

COVID-19
Global Veterinary Diagnostics Market by Product (Instruments, Consumables), Technology (Immunodiagnostics (Lateral Flow, ELISA), Clinical Biochemistry, PCR, Hematology, Urinalysis), Animal (Dog, Cat, Cattle, Pig, Poultry, Horse), End User - Global Forecast to 2027
Request COVID-19 impact analysis

Global Veterinary Diagnostics Market by Product (Instruments, Consumables), Technology (Immunodiagnostics (Lateral Flow, ELISA), Clinical Biochemistry, PCR, Hematology, Urinalysis), Animal (Dog, Cat, Cattle, Pig, Poultry, Horse), End User - Global Forecast to 2027

Published: Nov-2021 Report Code: MEDE2112 Available Format: Pages: 1-213
Category : Medical Devices
The global veterinary diagnostics market is expected to grow at a CAGR of ~x% from 2020 to reach ~x billion by 2027. The growth is primarily attributed to growing companion animal population, prevalence of zoonotic diseases, growing demand for animal health insurance, increasing expenditure on animal health, rising demand for animal derived foods and increasing number of veterinary practitioners. However, rising pet care expenses, lack of skilled veterinarians and limitation of diagnostic infrastructure are expected to hinder the growth of the market. Rising use of PCR testing for COVID-19 in animals by pet owners provide great opportunities for this market.



By Product: Consumable segment dominated the market in 2020
By product, veterinary diagnostic market is segmented consumables and instruments. Consumables segment accounted for largest market share of veterinary diagnostic market in 2020. The large share of this market segment can be attributed to grown demand of these products in veterinary hospitals, clinics & labs, adoption of point of care diagnostics by pet owners and rising awareness about zoonotic diseases. 

By Animal type: Companion animals accounted for the largest market share in 2020 
Companion animals segment accounted for the largest market share of the veterinary diagnostic market, by animal type in 2020. The dominant share of companion animal segment was captured by dogs. The large market share can be ascribed by increasing obesity, cancer, diabetes and other diseases and growing concern among pet owners. In livestock animal segment, pigs accounted for largest market share due to rising consumption of pork and diagnostic tests for them. 
By Technology: Molecular Diagnostics segment leaded the market in the forecast period
Based on technology, molecular diagnostics segment accounted for largest share of veterinary diagnostics market in the forecast period. The large share of this market segment can be attributed to growing usage of molecular diagnosis for the detection of veterinary diseases and reliable, specific & fast diagnosis. COVID-19 has further propelled the application for the rapid detection of virus in companion animals. 

By Region: North America expected to dominate the regional market
North America is expected to dominate the veterinary diagnostics market by region. The large share is primarily attributed to increasing population of companion & livestock animals, rising consumption of meat & dairy products, technological advancement, rising pet insurance and growing healthcare expenditure on animals. APAC is expected to register highest CAGR. The growth can be attributed to increasing disposable income, adoption of pet animals and high demand for animal protein.

Competitive Scenario
  • Thermo Fisher Scientific Inc. (US)
  • Zoetis Inc. (US)
  • IDEXX Laboratories Inc. (US)
  • NEOGEN Corporation (US)
  • Bio-Rad Laboratories Inc. (US)
  • bioMérieux SA (France)
  • Virbac (France)
  • Heska Corporation (US)
  • Bio-Rad Laboratories Inc. (US)
  • bioMérieux SA (France)
  • Virbac (France)
  • Heska Corporation (US)
  • Agrolabo S.p.A. (Italy)
  • INDICAL BIOSCIENCE GmbH (Germany)
  • Randox Laboratories Ltd. (Ireland)
  • IDvet (France)
  • Biopanda Reagents (UK)
  • Bionote Inc. (South Korea)
  • BioChek (Netherlands)
  • Fassisi GmbH (Germany)
  • Biogal Galed Labs (Israel)
  • Alvedia (France)
  • SKYER Inc. (South Korea)
  • Shenzhen Bioeasy Biotechnology Co. Ltd. (China)

*

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Global Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

Not able to find what you are looking for? Need customization in the existing report?
Click Here

Join SPER Panel

SPER

Market Research

We are the leading, full-service global market research and consulting company.

Secure Payments
SPER Payment Options
Connect with us